Sinew Pharma Inc. (TPEX:6634)
37.40
+5.40 (16.87%)
At close: Apr 17, 2026
Sinew Pharma Market Cap
Sinew Pharma has a market cap or net worth of 2.67 billion as of April 17, 2026. Its market cap has decreased by -24.24% in one year.
Market Cap
2.67B
Enterprise Value
1.63B
Revenue
47.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
37.40
Market Cap Chart
Since June 29, 2017, Sinew Pharma's market cap has increased from 1.90B to 2.67B, an increase of 40.26%. That is a compound annual growth rate of 3.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.67B | -4.51% |
| Dec 31, 2025 | 2.79B | -17.68% |
| Dec 31, 2024 | 3.39B | -29.30% |
| Dec 29, 2023 | 4.80B | -34.51% |
| Dec 30, 2022 | 7.33B | 29.47% |
| Dec 30, 2021 | 5.66B | 19.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apex Biotechnology | 2.96B |
| Intech Biopharm | 2.95B |
| Syngen Biotech | 2.87B |
| HeXun Biosciences | 2.80B |
| TWi Biotechnology | 2.70B |
| Sunhawk Vision Biotech | 2.65B |
| Genomics BioSci & Tech. | 2.59B |
| GlycoNex Incorporation | 2.58B |